mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
6e-05 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-05 |
mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
6e-05 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
8e-05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
8e-05 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
9e-05 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
9e-05 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |